KCAS Bio is proud to announce our participation in the 20th Annual Workshops on Recent Issues in Bioanalysis (WRIB), taking place from April 13th to April 17th, 2026, in Dallas, TX. As a leading event for the bioanalytical community, WRIB brings together global experts to share innovative solutions, discuss emerging trends, and tackle the pressing challenges in bioanalysis and related disciplines. Visit KCAS Bio at Booth #38 to engage with our experts and learn how we can move your projects forward.
KCAS Bio Scientific Poster at WRIB
Two KCAS Bio scientists will be presenting scientific posters highlighting key advancements in bioanalysis:
1. Ryan Darling, Associate Director of Mass Spectrometry Bioanalysis
Poster Title: “Method Development and Validation of a Biomarker Analog by Hybrid LC-MS/MS with Two-Dimensional Chromatography in Human Matrices”
Ryan will be presenting on how a validated hybrid immunoaffinity LC–MS/MS method using a surrogate peptide and 2D chromatography enables selective, sub-ng/mL quantitation of a KLK1 analog in human plasma, overcoming LBA limitations caused by near-identical endogenous KLK1. Poster P07. Ryan will be presenting on Thursday, April 16 – Day 3.
2. Taylor Dufield, Scientist I
Poster Title: “Method Development and Validation for the Determination of Two Protein Biomarkers by Multiplexed Online and Offline Hybrid LC-MS/MS in Human Heart Tissue”
Taylor’s poster presentation will discuss a fit-for-purpose multiplex LC–MS/MS workflow combining online and offline anti-peptide immunoprecipitation that enables sensitive, selective quantitation of protein biomarkers and binding partners from a single digested tissue sample across multiple species using a validated ICH M10-aligned approach. Poster P08. Taylor will be presenting on Thursday, April 16 – Day 3.
Innovating Bioanalytical Excellence
At KCAS Bio, innovation is at the core of everything we do. Our bioanalytical services are designed to address the complexities of modern therapeutic development, from biologics to advanced therapies. With cutting-edge instrumentation, validated methodologies, and a commitment to scientific excellence, we deliver reliable data to support regulatory submissions and therapeutic advancements.
Shaping the Future of Bioanalysis
WRIB 2026 serves as a critical platform for addressing both scientific and regulatory issues in bioanalysis. KCAS Bio’s expertise spans key areas, including pharmacokinetics, immunogenicity, and cell and gene therapy analytics, ensuring that we remain at the forefront of this ever-evolving field. By participating in discussions and workshops, we aim to not only share our insights but also learn from peers to further refine our services and strategies.
Meet KCAS Bio at WRIB 2026 in Dallas
The annual WRIB meeting is renowned for fostering collaboration among pharmaceutical, biotech, and regulatory professionals. We invite you to connect with KCAS Bio during WRIB 2026 to explore how our bioanalytical expertise can support your project’s success. Whether you’re navigating the complexities of assay development, seeking advanced analytics for cutting-edge therapies, or requiring regulatory-compliant bioanalysis, our team is here to provide tailored solutions. Contact us today to schedule a meeting at the conference.